PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Overall, these results underscore the notion that obese individuals carrying the PNPLA3 minor allele are, on the one hand, at risk of a rapid progression of NAFLD, and they might be the ones who, in particular, profit from weight-loss therapy and lifestyle modifications [33].